Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.0025.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.78% | 56.82% | 56.02% | 40.22% | -23.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.78% | 56.82% | 56.02% | 40.22% | -23.23% |
| Cost of Revenue | -12.06% | -11.99% | -40.78% | -19.29% | -43.28% |
| Gross Profit | 29.27% | 77.94% | 92.42% | 57.26% | -16.54% |
| SG&A Expenses | 3.12% | -28.24% | -32.65% | -38.10% | -43.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.14% | -27.33% | -33.14% | -37.21% | -43.63% |
| Operating Income | 8.44% | 53.47% | 58.27% | 58.52% | 50.72% |
| Income Before Tax | 14.03% | 38.83% | 44.77% | 45.55% | 33.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.03% | 38.83% | 44.77% | 45.55% | 33.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.03% | 38.83% | 44.77% | 45.55% | 33.74% |
| EBIT | 8.44% | 53.47% | 58.27% | 58.52% | 50.72% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 3.56% | 2.77% | 8.58% | 14.86% | 20.42% |
| Average Diluted Shares Outstanding | 3.56% | 2.77% | 8.58% | 14.86% | 20.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |